» Articles » PMID: 32329308

Higher Prevalence of Metabolic Syndrome in Child-adolescent Patients with Bipolar Disorder

Overview
Specialty Psychiatry
Date 2020 Apr 25
PMID 32329308
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Previous studies have indicated a convergent and bidirectional relationship between metabolic syndrome (MetS) and bipolar disorder (BD). As most of these studies focused mainly on adults diagnosed with BD, our study aims to investigate and characterize metabolic disturbances in child-adolescents diagnosed with BD.

Methods: We retrospectively examined the medical records of psychiatric hospitalizations with admitting diagnosis of BD in child-adolescents (age < 18 years). Body mass index (BMI), lipid profile, fasting blood glucose, and blood pressure were primary variables. National Cholesterol Education Program criteria were used to define MetS. Reference group data was obtained from the National Health and Nutrition Examination Survey study. Statistical analyses included t tests, chi-square tests, and Fisher's exact tests.

Results: We identified 140 child-adolescent patients with BD (mean age = 15.12 ± 1.70 years, 53% male). MetS was significantly more common in BD compared to the reference group: 14% (95% confidence interval [95% CI] 8-20) vs. 6.7% (95% CI 4.1-9.2), = 0.001 with no significant difference by sex. MetS components were higher in the BD group, particularly BMI ≥ 95% (25% vs. 11.8%, < 0.001) and high blood pressure (17% vs. 8%, = 0.05). Moreover, female patients had lower odds of high blood pressure (odds ratio = 0.24 [95% CI 0.08-0.69], = 0.005).

Conclusion: Compared with the general child-adolescent population, the prevalence of MetS was significantly higher in patients with BD of same age. This reiterates the notion of an increased risk of MetS in patients diagnosed with BD; and thus, further exploration is warranted.

Citing Articles

The bi-directional association between bipolar disorder and obesity: Evidence from Meta and bioinformatics analysis.

Kambey P, Kodzo L, Serojane F, Oluwasola B Int J Obes (Lond). 2023; 47(6):443-452.

PMID: 36806758 DOI: 10.1038/s41366-023-01277-6.


Cross-sectional and longitudinal associations between cardiometabolic measures and clinical stage in young people accessing early intervention mental health services.

Wilson C, Carpenter J, Crouse J, Park S, Koethe D, Scott E Early Interv Psychiatry. 2023; 17(9):893-900.

PMID: 36682384 PMC: 10946614. DOI: 10.1111/eip.13381.

References
1.
Fraguas D, Correll C, Merchan-Naranjo J, Rapado-Castro M, Parellada M, Moreno C . Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol. 2010; 21(8):621-45. DOI: 10.1016/j.euroneuro.2010.07.002. View

2.
Muller N, Weidinger E, Leitner B, Schwarz M . The role of inflammation in schizophrenia. Front Neurosci. 2015; 9:372. PMC: 4612505. DOI: 10.3389/fnins.2015.00372. View

3.
Duffy A, Horrocks J, Milin R, Doucette S, Persson G, Grof P . Adolescent substance use disorder during the early stages of bipolar disorder: a prospective high-risk study. J Affect Disord. 2012; 142(1-3):57-64. DOI: 10.1016/j.jad.2012.04.010. View

4.
Mehta J, Mahendran A, Bajaj R, Doshi A . Myocardial Ischemia with Cannabinoid Use in an Adolescent. Cureus. 2018; 9(11):e1899. PMC: 5790209. DOI: 10.7759/cureus.1899. View

5.
Almandil N, Liu Y, Murray M, Besag F, Aitchison K, Wong I . Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis. Paediatr Drugs. 2013; 15(2):139-50. DOI: 10.1007/s40272-013-0016-6. View